Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Market Cap	27.78B
Revenue (ttm)	1.98B
Net Income (ttm)	-2.00B
Shares Out	984.87M
EPS (ttm)	-2.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,976,400
Average Volume	2,409,356
Open	15.12
Previous Close	15.04
Day's Range	14.18 - 15.44
52-Week Range	9.17 - 21.70
Beta	0.50
RSI	63.20
Earnings Date	Mar 28, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,568
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2023, HKG:1877's revenue was 1.50 billion, an increase of 3.38% compared to the previous year's 1.45 billion. Losses were -2.28 billion, -4.38% less than in 2022.

Financial numbers in CNY